Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.

Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M.

Mod Pathol. 2000 Sep;13(9):988-93.

2.

Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.

Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, Coffin CM.

Am J Surg Pathol. 2001 Sep;25(9):1150-7.

PMID:
11688574
3.

An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.

Morotti RA, Nicol KK, Parham DM, Teot LA, Moore J, Hayes J, Meyer W, Qualman SJ; Children's Oncology Group.

Am J Surg Pathol. 2006 Aug;30(8):962-8.

PMID:
16861966
5.
6.

Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.

Ishiguro N, Motoi T, Osaki M, Araki N, Minamizaki T, Moriyama M, Ito H, Yoshida H.

Hum Pathol. 2005 Jun;36(6):620-5.

PMID:
16021567
7.

Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.

Paner GP, McKenney JK, Epstein JI, Amin MB.

Am J Surg Pathol. 2008 Jul;32(7):1022-8. doi: 10.1097/PAS.0b013e3181650e4a.

PMID:
18469707
8.

The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.

Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, Huff D.

Mod Pathol. 2002 Oct;15(10):1080-6.

10.
11.

Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.

Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM.

Am J Pathol. 1995 Dec;147(6):1799-810.

12.

Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.

Tonin PN, Scrable H, Shimada H, Cavenee WK.

Cancer Res. 1991 Oct 1;51(19):5100-6.

14.

Second primary rhabdomyosarcomas in patients with bilateral retinoblastoma: a clinicopathologic and immunohistochemical study.

Hasegawa T, Matsuno Y, Niki T, Hirohashi S, Shimoda T, Takayama J, Watanabe C, Kaneko A, Sano T, Sato M, Suzuki J.

Am J Surg Pathol. 1998 Nov;22(11):1351-60.

PMID:
9808127
15.

Polymerase chain reaction-based diagnosis of rhabdomyosarcomas: comparison of fetal type acetylcholine receptor subunits and myogenin.

Gattenlöhner S, Müller-Hermelink HK, Marx A.

Diagn Mol Pathol. 1998 Jun;7(3):129-34.

PMID:
9836066
16.

Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors.

Miettinen M, Chatten J, Paetau A, Stevenson A.

Am J Surg Pathol. 1998 Mar;22(3):327-32.

PMID:
9500774
17.

Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.

Hostein I, Andraud-Fregeville M, Guillou L, Terrier-Lacombe MJ, Deminière C, Ranchère D, Lussan C, Longavenne E, Bui NB, Delattre O, Coindre JM.

Cancer. 2004 Dec 15;101(12):2817-24.

18.

Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.

Bahrami A, Gown AM, Baird GS, Hicks MJ, Folpe AL.

Mod Pathol. 2008 Jul;21(7):795-806. doi: 10.1038/modpathol.2008.86. Epub 2008 May 16.

20.

Supplemental Content

Support Center